Medications for Alzheimer's disease

Benefits of currently approved drugs are limited, but research continues.

Thanks to longer life expectancy, the senior population is steadily growing in the United States. A 2010 report from the Alzheimer's Association estimates that, by 2030, the 65+ population will be 71 million — double what it is today. By then, the number of people with Alzheimer's disease will be 7.7 million, more than a 50% increase from the 5.1 million people ages 65 and over currently suffering from the disease.